Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
J.AllenE
Koeth et al., 2019)
Shopping for cheaper alternatives
While most acute gastrointestinal toxicity is transient and can be managed with supportive care, a subset of patients experience serious symptoms, leading to discontinuation of the treatment
These results suggest that using PepT1 to deliver KPV could be a promising way to control gut inflammation in IBD
Clinical validity : Does the biomarker actually reflect a real health risk or condition, and do we know what to do about it
US$ 28.29
US$ 24.94
US$ 25.00
US$ 24.53
US$ 24.74
